Found 14 matching trials
Solriamfetol in Binge Eating Disorder PHASE4 The goal of this project is to evaluate the efficacy and tolerability of th...
Show More Location
Lindner Center of HOPE
Learn More & Join Trial
A Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With ADHD PHASE3 This study is a Phase 3, multi-center, randomized, 6-week, double-blind, pl...
Show More Location
Clinical Research Site
Learn More & Join Trial
Efficacy and Tolerance of Solriamfetol in Patients Affected with Idiopathic Hypersomnia. PHASE2 This Phase II clinical trial is a monocenter, double-blind, randomized, pla...
Show More Location
University Hospital of Montpellier
Learn More & Join Trial
RECOVER-SLEEP: Platform Protocol PHASE2 The platform protocol is designed to be flexible so that it is suitable for...
Show More Location
Banner University Medical Center Phoenix
Learn More & Join Trial
RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia) PHASE2 The platform protocol is designed to be flexible so that it is suitable for...
Show More Location
All sites listed under NCT06404086
Learn More & Join Trial
Evaluate Sunosi® PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral Administration PHASE1 The purpose of study JZP110-401 is to evaluate solriamfetol pharmacokinetic...
Show More Location
M3-Wake Research, Inc.
Learn More & Join Trial
Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma PHASE2 This phase II trial studies the side effects of solriamfetol in improving s...
Show More Location
Wake Forest Baptist Comprehensive Cancer Center
Learn More & Join Trial
A Study to Assess the Efficacy and Safety of Solriamfetol in Children With ADHD PHASE3 This study is a Phase 3, multi-center, randomized, 6-week, double-blind, pl...
Show More Location
Clinical Research Site
Learn More & Join Trial
SUNOSI® (Solriamfetol) Pregnancy Registry N/A The SUNOSI (solriamfetol) Pregnancy Registry is a prospective, multi-countr...
Show More Location
Evidera, a PPD business unit
Learn More & Join Trial
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Solriamfetol in the Treatment of Excessive Daytime Sleepiness (EDS) in Patients with Obstructive Sleep Apnea (OSA) PHASE3 The purpose of this study is to evaluate the efficacy and safety of 12-week...
Show More Location
Shanghai Sixth People's Hospital
Learn More & Join Trial